INTECH Investment Management’s Oric Pharmaceuticals ORIC Stock Holding History

INTECH Investment Management’s Portfolio ORIC Stock Details ORIC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$218K	Buy	20,143 +1,012	+5%	+$9.18K	﹤0.01%	1751
2026 Q1	$242K	Sell	19,131 -7,475	-28%	-$84.9K	﹤0.01%	1663
2025 Q4	$218K	Buy	26,606 +9,223	+53%	+$106K	﹤0.01%	1936
2025 Q3	$209K	Sell	17,383 -8,064	-32%	-$84.8K	﹤0.01%	2041
2025 Q2	$258K	Sell	25,447 -15,319	-38%	-$103K	﹤0.01%	1959
2025 Q1	$227K	Buy	40,766 +12,053	+42%	+$105K	﹤0.01%	2029
2024 Q4	$232K	Buy	28,713 +9,245	+47%	+$84.8K	﹤0.01%	1967
2024 Q3	$200K	Buy	+19,468	New	+$192K	﹤0.01%	1719

Other funds holding ORIC

Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

SOCM

SR One Capital Management Wayne, Pennsylvania $1.04B AUM 262.99% 1-Year Est. Return

VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

INTECH Investment Management's ORIC Position: Q2 2026 in Review

INTECH Investment Management increased its Oric Pharmaceuticals (ORIC) stake by 5.3% in Q2 2026, buying an estimated $9.18K and bringing the position to 20,143 shares worth $218K. The position accounts for ﹤0.01% of the portfolio, ranked #1751.

INTECH Investment Management first reported a position in ORIC in Q3 2024 and has held it in 8 quarters since. The position peaked at $258K in Q2 2025. 180 funds tracked by Wall St. Rank hold ORIC as of Q2 2026.

INTECH Investment Management held 20,143 shares of Oric Pharmaceuticals worth $218K as of Q2 2026.
INTECH Investment Management bought 1,012 Oric Pharmaceuticals shares in Q2 2026, an estimated $9.18K.
Oric Pharmaceuticals made up ﹤0.01% of INTECH Investment Management's portfolio in Q2 2026, its #1751 holding.
INTECH Investment Management first reported a position in Oric Pharmaceuticals in Q3 2024 and has held it in 8 quarters since.
INTECH Investment Management's Oric Pharmaceuticals position peaked at $258K in Q2 2025.
180 funds tracked by Wall St. Rank held Oric Pharmaceuticals as of Q2 2026.

Based on INTECH Investment Management's 13F filing for Q2 2026, filed 10 Aug 2026.